[
  {
    "ts": "2024-12-04T16:40:56+00:00",
    "headline": "Edwards Lifesciences Outlines Vision For Growth At Investor Conference",
    "summary": "On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies. The company, now exclusively focused on structural heart solutions, emphasized its robust technology pipeline, financial guidance, and expanding opportunities in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT). Also Read: Morgan Stanley Maintains Pos",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-vision-growth-164056670.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "61364fef-3da9-3d10-a764-3cfaaae50886",
      "content": {
        "id": "61364fef-3da9-3d10-a764-3cfaaae50886",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Outlines Vision For Growth At Investor Conference",
        "description": "",
        "summary": "On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies. The company, now exclusively focused on structural heart solutions, emphasized its robust technology pipeline, financial guidance, and expanding opportunities in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT). Also Read: Morgan Stanley Maintains Pos",
        "pubDate": "2024-12-04T16:40:56Z",
        "displayTime": "2024-12-04T16:40:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/0fa6fc6dccabc89762cc64000bdf087d",
          "originalWidth": 983,
          "originalHeight": 553,
          "caption": "Edwards Lifesciences Outlines Vision For Growth At Investor Conference",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kizUHj.oPcXyPk8hTEBSxA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/0fa6fc6dccabc89762cc64000bdf087d.cf.webp",
              "width": 983,
              "height": 553,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_mlQttAr9NuWKktwTTic_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/0fa6fc6dccabc89762cc64000bdf087d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-vision-growth-164056670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-vision-growth-164056670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2024-12-04T11:00:00+00:00",
    "headline": "Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference",
    "summary": "NEW YORK, December 04, 2024--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong position with major growth drivers in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tri",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-growth-strategy-110000606.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "72fedb44-1a49-31e5-91e5-0ccd5506b0c5",
      "content": {
        "id": "72fedb44-1a49-31e5-91e5-0ccd5506b0c5",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference",
        "description": "",
        "summary": "NEW YORK, December 04, 2024--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong position with major growth drivers in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tri",
        "pubDate": "2024-12-04T11:00:00Z",
        "displayTime": "2024-12-04T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f8ab201225ff8d21d78c580af111957b",
          "originalWidth": 392,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EHc6ZQAU_q9EhogAu7b8fw--~B/aD00ODA7dz0zOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f8ab201225ff8d21d78c580af111957b.cf.webp",
              "width": 392,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ltPhiWTrz88FK.VF6ITfXg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f8ab201225ff8d21d78c580af111957b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-growth-strategy-110000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-outlines-growth-strategy-110000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]